Cargando…

Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies

Interstitial lung disease (ILD) is a prognostic factor for poor outcome in polymyositis (PM)/dermatomyositis (DM). The appropriate management of ILD is very important to improve the prognosis of patients with PM/DM. ILD activity and severity depend on the disease subtype. Therefore, clinicians shoul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawasumi, Hidenaga, Gono, Takahisa, Kawaguchi, Yasushi, Yamanaka, Hisashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514184/ https://www.ncbi.nlm.nih.gov/pubmed/26279636 http://dx.doi.org/10.4137/CCRPM.S23313

Ejemplares similares

IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis
por: Kawasumi, Hidenaga, et al.
Publicado: (2014)

Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan
por: Kawasumi, Hidenaga, et al.
Publicado: (2016)

Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy
por: Gono, Takahisa, et al.
Publicado: (2013)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Yoshifuji, Hajime
Publicado: (2016)

Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease
por: Cao, Heng, et al.
Publicado: (2022)

Interstitial Lung Disease with ANCA-associated Vasculitis
por: Katsumata, Yasuhiro, et al.
Publicado: (2015)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
por: Tochimoto, Akiko, et al.
Publicado: (2016)

Expression of Inflammatory Markers in the Muscles of Patients with Idiopathic Inflammatory Myopathy According to the Presence of Interstitial Lung Disease
por: Lee, Jung Sun, et al.
Publicado: (2022)

A Clinical Analysis of Risk Factors for Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myopathy
por: Cen, Xiaomin, et al.
Publicado: (2013)

Idiopathic inflammatory myopathies and the lung
por: Lega, Jean-Christophe, et al.
Publicado: (2015)

Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
por: Hervier, Baptiste, et al.
Publicado: (2020)

Recent advances in the immunogenetics of idiopathic inflammatory myopathy
por: Chinoy, Hector, et al.
Publicado: (2011)

Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease
por: Kamiya, Hiroyuki, et al.
Publicado: (2018)

Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
por: Liang, Junyu, et al.
Publicado: (2021)

Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy
por: Bai, Zhiqian, et al.
Publicado: (2021)

The Efficacy and Safety of Rituximab in Patients with Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: Case Series
por: Jang, Youngeun, et al.
Publicado: (2023)

Association between a C8orf13–BLK Polymorphism and Polymyositis/Dermatomyositis in the Japanese Population: An Additive Effect with STAT4 on Disease Susceptibility
por: Sugiura, Tomoko, et al.
Publicado: (2014)

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
por: Nishina, Naoshi, et al.
Publicado: (2020)

Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: A case-control study
por: Baba, Sayumi, et al.
Publicado: (2011)

Prognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysis
por: Kamiya, Hiroyuki, et al.
Publicado: (2016)

Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients
por: Li, Yuhui, et al.
Publicado: (2020)

Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study
por: Liang, Junyu, et al.
Publicado: (2020)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody
por: Miyamae, Takako, et al.
Publicado: (2018)

Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy
por: Gono, Takahisa, et al.
Publicado: (2022)

Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
por: Kaieda, Shinjiro, et al.
Publicado: (2020)

The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
por: Liang, Junyu, et al.
Publicado: (2021)

Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies
por: Oldroyd, Alexander, et al.
Publicado: (2018)

Drugs in induction and treatment of idiopathic inflammatory myopathies
por: Iaccarino, Luca, et al.
Publicado: (2014)

Resistin in idiopathic inflammatory myopathies
por: Filková, Mária, et al.
Publicado: (2012)

Malignancy and Idiopathic Inflammatory Myopathies
por: Ungprasert, Patompong, et al.
Publicado: (2013)

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Idiopathic inflammatory myopathies overlapping with systemic diseases
por: Lepreux, Sébastien, et al.
Publicado: (2018)

Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
por: Stuhlmüller, Bruno, et al.
Publicado: (2019)

Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies
por: Patel, Aarat, et al.
Publicado: (2016)

Imaging biomarkers in the idiopathic inflammatory myopathies
por: Zubair, Adeel S., et al.
Publicado: (2023)

Cardiovascular manifestations in idiopathic inflammatory myopathies
por: Shah, Meera, et al.
Publicado: (2023)

Increased prevalence of celiac disease in idiopathic inflammatory myopathies
por: Danielsson, Olof, et al.
Publicado: (2017)

Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis
por: Rothwell, Simon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_98usr29umouagkh3r4s8cht9g9